Fingerprint
Dive into the research topics of 'Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis
Arturo Vega-Ruiz, Jorge E. Cortes, Matjaz Sever, Taghi Manshouri, Alfonso Quintás-Cardama, Raja Luthra, Hagop M. Kantarjian, Srdan Verstovsek
Research output: Contribution to journal › Article › peer-review
127
Scopus
citations